Very recently, Liu et al. suggested the possibility to ameliorate isoproterenol-induced cardiac hypertrophy through suppression of CaR signalling with the CaR inhibitor Chalex 231 both in vivo and in vitro [232]. This evidence concerns the gene CASR and cardiac hypertrophy.